In plain English
Bristol‑Myers Squibb Co. develops and sells prescription medicines, focusing on oncology and immunology treatments. The company is a…
Company stock · NYSE · USD
BMY
Bristol-Myers Squibb Co
$61.48
Today
−$1.52-2.41%
vs yesterday’s close
Live price
- Opened at
- $62.66
- Day high
- $62.84
- Day low
- $61.31
- Yesterday’s close
- $63.00
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Size
- Medium-sized company
- Market value
- $125.6 billion
- Number of shares
- 2.04 billion
- Country
- US
- Went public
- Mar 17, 1980
- Exchange
- NYSE
- Website
- bms.com
Price chart Pro
Loading chart…
Loading chart…
Company briefing
What BMY is
Plain English context — why the name shows up in the news, and what to watch next.
Latest on this name
Insights & deeper context
2 recent cards — open any for the full deeper dive.
Tempus AI Doubles Down On Moderna and Merck Cancer Vaccine Infrastructure
In brief
Tempus is deepening ties with Moderna and Merck on a personalized cancer vaccine, but the deal’s financial upside remains unclear, weighing on its stock price today.
Big Pharma's Future Growth Rests on Chinese Science? Expert Says: 'We Can't Ban Our Way Out of This'
In brief
China's rise in biotech threatens the US's competitive edge and access to new cancer drugs.
Company reports
Official filings (US SEC and linked cards)
No filings here yet
Official report cards for BMY will show up here when available.
Broad market indexes (like the S&P 500, a basket of 500 large US companies) are shown through popular funds that track them (for example SPY). Company profile and prices use live market data when available.